Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

721
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
721
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

287
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
287
Tumor Progression02:07

Tumor Progression

6.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.6K
Dementia01:30

Dementia

208
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
208
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

808
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
808

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating Metabolic, Perfusion, and Microstructural Parameters for Quantitative Neuroimaging in Rare Neurodegenerative Diseases: A Hybrid PET/MRI Approach.

Diagnostics (Basel, Switzerland)·2026
Same author

Joint trajectories of brain atrophy, white matter hyperintensities and cognition quantify brain maintenance.

Nature communications·2026
Same author

Trajectories of brain structure and function in young adult carriers of genetic frontotemporal dementia variants.

medRxiv : the preprint server for health sciences·2026
Same author

Thyroid hormones and energy metabolism in amyotrophic lateral sclerosis.

Brain communications·2026
Same author

Serum neurofilaments for motoneuron and dementia diseases: a German multicenter cohort study.

Journal of neurology·2026
Same author

IgLON5 autoimmune antibodies activate Tau via neuronal hyperactivity.

Science advances·2026

Related Experiment Video

Updated: Oct 7, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K

Predicting disease progression in behavioral variant frontotemporal dementia.

Sarah Anderl-Straub1, Ludwig Lausser2, Jolina Lombardi1

  • 1Department of Neurology University of Ulm Ulm Germany.

Alzheimer'S & Dementia (Amsterdam, Netherlands)
|January 10, 2022
PubMed
Summary

Magnetic resonance imaging (MRI) biomarker profiles can predict the progression of behavioral variant of frontotemporal dementia (bvFTD). This research identifies key brain regions for forecasting individual patient decline with 80% accuracy.

Keywords:
behavioral variant frontotemporal dementiabrain volumeclassification modelsdisease progressionfrontotemporal dementiaprognosis

More Related Videos

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.8K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.6K

Related Experiment Videos

Last Updated: Oct 7, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.8K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.6K

Area of Science:

  • Neuroimaging
  • Neurodegenerative diseases
  • Biomarker discovery

Background:

  • Behavioral variant of frontotemporal dementia (bvFTD) is a rare neurodegenerative disorder.
  • Predictors for bvFTD progression remain insufficiently identified.
  • Magnetic resonance imaging (MRI) is a key tool for studying brain structure.

Purpose of the Study:

  • To investigate multivariate MRI biomarker profiles for predicting individual decline in bvFTD.
  • To identify reliable predictors of disease progression.
  • To assess the feasibility of an individualized prognosis model.

Main Methods:

  • Recruited 105 bvFTD patients from the German FTLD consortium.
  • Defined patient groups as "fast progressors" and "slow progressors".
  • Utilized multivariate classification models to screen MR brain volumes for predictive value.

Main Results:

  • Identified specific brain regions predicting disease progression within one year.
  • Achieved 80% prediction accuracy across top classification models.
  • Highlighted the pallidum, middle temporal gyrus, inferior frontal gyrus, cingulate gyrus, middle orbitofrontal gyrus, and insula as key predictors.

Conclusions:

  • Combinations of MRI-based biomarkers can enable individual prognosis for bvFTD patients.
  • This approach may facilitate individualized progression models in clinical studies.
  • The findings support the use of neuroimaging biomarkers for personalized patient management.